Latest Vaccine News

UsualName said:
Moderna is going to the moon because it’s a good company with a good product and big growth potential beyond Covid.

As far as vaccine policy, no we should not take vaccine availability from kids here for people elsewhere. It’s just not good policy. It’s a policy of subtraction, not addition. You don’t rob Peter to pay Paul, as the old saying goes.

There is a real issue in the developing world that many countries won’t have significant vaccine access until 2022. The answer is not and should never be either or but moving toward all. To get to a place where we can do that requires increased vaccine production capacity. It makes so much better sense than juggling limited doses on a global scale and imagine the logistics of it all. It doesn’t make good sense.
More...

We can save many lives around the world and fulfill our responsibility as a world leader after having taken care of adults in this country. The kids are not at high risk. You have to be able to walk and chew gum at the same time.

We are almost at the height of the delta variant. Even so and without vaccinating kids, only about 5-10 people a day are dying in NYC as a result of covid. Most are high risk individuals and they should have gotten a vaccine if they wanted to live, not the kids.

I am an America First person but not a Canadian who robs the third world for vaccine. Once we have taken care of our critical populations, which we have or the vaccine is there for them, we should not be hoarding it, especially to foist it upon kids.

You could send that vaccine into a province in some african country and save tens of thousands of adults.

Shame on you. You are like the Canadians who produced no vaccine but have now hoarded more doses than their entire population requires because they want it for themselves or to hand it out for political power to select countries.

Shame on you. You are just a greedy American thinking about what is best for your Moderna stock.
 
Last edited:
TreeFrogTrader said:
We can save many lives around the world and fulfill our responsibility as a world leader after having taken care of adults in this country. The kids are not at high risk. You have to be able to walk and chew gum at the same time.

We are almost at the height of the delta variant. Even so and without vaccinating kids, only about 5-10 people a day are dying in NYC as a result of covid. Most are high risk individuals and they should have gotten a vaccine if they wanted to live, not the kids.

I am an America First person but not a Canadian who robs the third world for vaccine. Once we have taken care of our critical populations, which we have or the vaccine is there for them, we should not be hoarding it, especially to foist it upon kids.

You could send that vaccine into a province in some african country and save tens of thousands of adults.

Shame on you. You are like the Canadians who produced no vaccine but have now hoarded more doses than their entire population requires because they want it for themselves or to hand it out for political power to select countries.

Shame on you. You are just a greedy American thinking about what is best for your Moderna stock.
More...

Your “foisting on kids” is another parent’s protecting their children and family. This isn’t about hoarding anything. We are already sending excess vaccines where we can, and to some consternation may I add.
 
UsualName said:
Your “foisting on kids” is another parent’s protecting their children and family. This isn’t about hoarding anything. We are already sending excess vaccines where we can, and to some consternation may I add.
More...

Shameful.

If you cannot be a conservative, at least be an old school liberal with some honor.
 
TreeFrogTrader said:
Shameful.

If you cannot be a conservative, at least be an old school liberal with some honor.
More...

Again, this is a matter of policy. The correct policy is to expand capacity, not juggle vaccinations and transport them across the globe.

You seem to think vaccinating children won’t save lives here in America but it actually will. Not only children but the people they might transmit virus to.
 
UsualName said:
Again, this is a matter of policy. The correct policy is to expand capacity, not juggle vaccinations and transport them across the globe.
More...


Transporting them across the globe when adults and high risk children have had access to vaccine is the honorable way to go.

As I have said. America First, but then our cup must runneth over to help the rest of the world as is our destiny. If you have a few million shots that you want kids to take and there is no demand for them, load them up and send them to a third world country and save tens of thousands of lives.

Your ilk will never see the day when you don't need to hold on to them. You have booster shots on top of your booster shots as far as the eye can see.

Priorities must be set. No American should lose out on a vaccine if they want one. Holding on to millions of shots and trying to talk young children into taking them is secondary to high risk adults who may be non-Americans.

Stop thinking of your Moderna stock.
 
China's Sinovac COVID-19 Vaccine Only 58% Effective Against COVID-19: Study
https://www.ibtimes.com/chinas-sino...y-58-effective-against-covid-19-study-3266622
  • The study observed 8.6 million Chileans who received Sinovac between February and July
  • A health official said a reduction in effectiveness is expected
  • A separate study showed that a third dose of Sinovac could increase antibody levels by three-fold
China’s Sinovac vaccine is only 58.5% effective against preventing symptomatic COVID-19, Chilean health authorities said this week.

The latest data from a “real world” study published by Chilean health officials found that Sinovac’s CoronaVac vaccine is only 58.5% effective against preventing symptomatic cases of the novel coronavirus. The study examined a group of 8.6 million residents who received the vaccine between February and July, Reuters reported.

In comparison, data from the same study and published in April showed that the shot was 67% effective in preventing a symptomatic infection, according to Bloomberg.

The latest data also found that Sinovac has an 86% effectiveness in preventing hospitalizations, 89.7% in preventing admission to intensive care units and 86% in preventing COVID deaths. These show increase in April data figures, wherein the vaccine was only 85% effective in preventing hospitalizations, 89% effective in preventing ICU admission and 80% effective in preventing deaths.

Chilean health official Dr. Rafael Araos said a reduction in the vaccine’s effectiveness was expected, especially with the emergence of new and more contagious variants.

"If Delta becomes more prevalent and the vaccine has a weaker response, we could observe a faster fall (in effectiveness)," he said during a press conference on Tuesday.

The data comes after a study published on medRxiv last week found that a third shot of the Sinovac COVID-19 vaccine given six to eight months after the second dose could generate a remarkable increase in antibody levels in recipients.

Among the 540 study participants who received the third dose, the levels of neutralizing antibody increased three-fold two weeks after the shot.

The study also found that giving a third dose 28 days after the second dose induced only a third of the antibody levels compared with a third dose given half a year after the second dose, Global Times noted.

The real-world data also comes after China’s Shanghai Fosun Pharmaceutical, in late July, announced that it was partnering with BioNTech to develop a booster vaccine using mRNA technology, similar to that used in COVID-19 vaccines developed by Pfizer and Moderna.

The shot, which is expected to be called Comirnaty, will begin its domestic trial production by the end of the month. It is currently in the administrative review stage.
 
gwb-trading said:
China's Sinovac COVID-19 Vaccine Only 58% Effective Against COVID-19: Study
https://www.ibtimes.com/chinas-sino...y-58-effective-against-covid-19-study-3266622
  • The study observed 8.6 million Chileans who received Sinovac between February and July
  • A health official said a reduction in effectiveness is expected
  • A separate study showed that a third dose of Sinovac could increase antibody levels by three-fold
China’s Sinovac vaccine is only 58.5% effective against preventing symptomatic COVID-19, Chilean health authorities said this week.

The latest data from a “real world” study published by Chilean health officials found that Sinovac’s CoronaVac vaccine is only 58.5% effective against preventing symptomatic cases of the novel coronavirus. The study examined a group of 8.6 million residents who received the vaccine between February and July, Reuters reported.

In comparison, data from the same study and published in April showed that the shot was 67% effective in preventing a symptomatic infection, according to Bloomberg.

The latest data also found that Sinovac has an 86% effectiveness in preventing hospitalizations, 89.7% in preventing admission to intensive care units and 86% in preventing COVID deaths. These show increase in April data figures, wherein the vaccine was only 85% effective in preventing hospitalizations, 89% effective in preventing ICU admission and 80% effective in preventing deaths.

Chilean health official Dr. Rafael Araos said a reduction in the vaccine’s effectiveness was expected, especially with the emergence of new and more contagious variants.

"If Delta becomes more prevalent and the vaccine has a weaker response, we could observe a faster fall (in effectiveness)," he said during a press conference on Tuesday.

The data comes after a study published on medRxiv last week found that a third shot of the Sinovac COVID-19 vaccine given six to eight months after the second dose could generate a remarkable increase in antibody levels in recipients.

Among the 540 study participants who received the third dose, the levels of neutralizing antibody increased three-fold two weeks after the shot.

The study also found that giving a third dose 28 days after the second dose induced only a third of the antibody levels compared with a third dose given half a year after the second dose, Global Times noted.

The real-world data also comes after China’s Shanghai Fosun Pharmaceutical, in late July, announced that it was partnering with BioNTech to develop a booster vaccine using mRNA technology, similar to that used in COVID-19 vaccines developed by Pfizer and Moderna.

The shot, which is expected to be called Comirnaty, will begin its domestic trial production by the end of the month. It is currently in the administrative review stage.
More...

huh, good to know it's comparable to Pfeizer at preventing serious illness and death. No wonder Chile's doing so well.
 
Cuddles said:
huh, good to know it's comparable to Pfeizer at preventing serious illness and death. No wonder Chile's doing so well.
More...

Actually the Chinese Sinovac vaccine is not comparable to Pfizer. Pfizer is far more effective as outlined in the same Chilean study.

Chilean study shows variations in success of COVID-19 vaccines
https://www.reuters.com/business/he...eventing-illness-chile-real-world-2021-08-03/

Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic illness among millions of Chileans who received it between February and July, the Chilean health authorities said on Tuesday, while Pfizer's COVID-19 shot was 87.7% effective and AstraZeneca's was 68.7% effective.

The data came in the latest "real world" data published by the Chilean authorities into the effectiveness among its population of a raft of COVID-19 vaccines.

Chile began one of the world's fastest inoculation campaigns against COVID-19 in December, having now fully vaccinated more than 60% of its population, predominantly with Sinovac's (SVA.O)CoronaVac.

That vaccine was 86% effective in preventing hospitalization, 89.7% effective in preventing admission to intensive care units and 86% effective in preventing deaths within the population between February and July, health official Dr Rafael Araos said in a press conference on Tuesday.

In April, the same study found that CoronaVac was 67% effective in preventing symptomatic illness, 85% effective in preventing hospitalizations and 80% effective in preventing deaths, suggesting its capacity to prevent the more serious impacts of the virus has strengthened, while its capacity to stop symptomatic illness diminished.

Araos said a reduction in protection from vaccines was inevitable over time, particularly with the arrival and growing prevalence of more virulent strains such as the Delta variant.

"If Delta becomes more prevalent and the vaccine has a weaker response, we could observe a faster fall (in effectiveness)," he said, adding his voice to calls for a third, booster dose to be issued.

The government also published data on the effectiveness of other vaccines administered in Chile, made by Pfizer BioNTech (PFE.N), (22UAy.DE) and AstraZeneca (AZN.L).

Pfizer's vaccine was 87.7% effective in preventing symptomatic COVID-19 in the same period, 98% effective in preventing intensive care admission and 100% effective in preventing death, Araos said.

AstraZeneca's was 68.7% effective in preventing symptomatic COVID-19 in the same period, 98% effective in preventing intensive care admissions and 100% effective in preventing death, Araos said.

Chile's study examined the vaccines' effectiveness among different cohorts of people who either received two doses of the specified vaccine, partial doses of the vaccine or no vaccine at all.

The CoronaVac part of the study examined a group of 8.6 million people, the Pfizer BioNTech part studied a group of 4.5 million people and the AstraZeneca part looked at a group of 2.3 million people.
 
You must log in or register to reply here.
Back
Top